3.23.2 html 172 295 1 false 67 0 false 8 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.petrospharma.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.petrospharma.com/role/StatementCondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.petrospharma.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.petrospharma.com/role/StatementCondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.petrospharma.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 00400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.petrospharma.com/role/StatementCondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 10101 - Disclosure - Nature of Operations, Basis of Presentation, Liquidity and Going Concern Sheet http://www.petrospharma.com/role/DisclosureNatureOfOperationsBasisOfPresentationLiquidityAndGoingConcern Nature of Operations, Basis of Presentation, Liquidity and Going Concern Notes 7 false false R8.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.petrospharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 10301 - Disclosure - Accounts Receivable, net Sheet http://www.petrospharma.com/role/DisclosureAccountsReceivableNet Accounts Receivable, net Notes 9 false false R10.htm 10401 - Disclosure - Inventories Sheet http://www.petrospharma.com/role/DisclosureInventories Inventories Notes 10 false false R11.htm 10501 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.petrospharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 11 false false R12.htm 10601 - Disclosure - Intangible Assets Sheet http://www.petrospharma.com/role/DisclosureIntangibleAssets Intangible Assets Notes 12 false false R13.htm 10701 - Disclosure - Accrued Expenses Sheet http://www.petrospharma.com/role/DisclosureAccruedExpenses Accrued Expenses Notes 13 false false R14.htm 10801 - Disclosure - Debt Sheet http://www.petrospharma.com/role/DisclosureDebt Debt Notes 14 false false R15.htm 10901 - Disclosure - Operating Leases Sheet http://www.petrospharma.com/role/DisclosureOperatingLeases Operating Leases Notes 15 false false R16.htm 11001 - Disclosure - Stock Options and Restricted Stock Units ("RSU's") Sheet http://www.petrospharma.com/role/DisclosureStockOptionsAndRestrictedStockUnitsrsuS Stock Options and Restricted Stock Units ("RSU's") Notes 16 false false R17.htm 11101 - Disclosure - Common Stock Warrants Sheet http://www.petrospharma.com/role/DisclosureCommonStockWarrants Common Stock Warrants Notes 17 false false R18.htm 11201 - Disclosure - Basic and Diluted Net Income (Loss) per Common Share Sheet http://www.petrospharma.com/role/DisclosureBasicAndDilutedNetIncomeLossPerCommonShare Basic and Diluted Net Income (Loss) per Common Share Notes 18 false false R19.htm 11301 - Disclosure - Marketing, Licensing and Distribution Agreements Sheet http://www.petrospharma.com/role/DisclosureMarketingLicensingAndDistributionAgreements Marketing, Licensing and Distribution Agreements Notes 19 false false R20.htm 11401 - Disclosure - Commitments and Contingencies Sheet http://www.petrospharma.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 20 false false R21.htm 11501 - Disclosure - Segment Information Sheet http://www.petrospharma.com/role/DisclosureSegmentInformation Segment Information Notes 21 false false R22.htm 11601 - Disclosure - Subsequent Events Sheet http://www.petrospharma.com/role/DisclosureSubsequentEvents Subsequent Events Notes 22 false false R23.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.petrospharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.petrospharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies 23 false false R24.htm 30303 - Disclosure - Accounts Receivable, net (Tables) Sheet http://www.petrospharma.com/role/DisclosureAccountsReceivableNetTables Accounts Receivable, net (Tables) Tables http://www.petrospharma.com/role/DisclosureAccountsReceivableNet 24 false false R25.htm 30403 - Disclosure - Inventories (Tables) Sheet http://www.petrospharma.com/role/DisclosureInventoriesTables Inventories (Tables) Tables http://www.petrospharma.com/role/DisclosureInventories 25 false false R26.htm 30503 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.petrospharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.petrospharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets 26 false false R27.htm 30603 - Disclosure - Intangible Assets (Tables) Sheet http://www.petrospharma.com/role/DisclosureIntangibleAssetsTables Intangible Assets (Tables) Tables http://www.petrospharma.com/role/DisclosureIntangibleAssets 27 false false R28.htm 30703 - Disclosure - Accrued Expenses (Tables) Sheet http://www.petrospharma.com/role/DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.petrospharma.com/role/DisclosureAccruedExpenses 28 false false R29.htm 30803 - Disclosure - Debt (Tables) Sheet http://www.petrospharma.com/role/DisclosureDebtTables Debt (Tables) Tables http://www.petrospharma.com/role/DisclosureDebt 29 false false R30.htm 30903 - Disclosure - Operating Leases (Tables) Sheet http://www.petrospharma.com/role/DisclosureOperatingLeasesTables Operating Leases (Tables) Tables http://www.petrospharma.com/role/DisclosureOperatingLeases 30 false false R31.htm 31003 - Disclosure - Stock Options and Restricted Stock Units ("RSU's") (Tables) Sheet http://www.petrospharma.com/role/DisclosureStockOptionsAndRestrictedStockUnitsrsuSTables Stock Options and Restricted Stock Units ("RSU's") (Tables) Tables http://www.petrospharma.com/role/DisclosureStockOptionsAndRestrictedStockUnitsrsuS 31 false false R32.htm 31103 - Disclosure - Common Stock Warrants (Tables) Sheet http://www.petrospharma.com/role/DisclosureCommonStockWarrantsTables Common Stock Warrants (Tables) Tables http://www.petrospharma.com/role/DisclosureCommonStockWarrants 32 false false R33.htm 31203 - Disclosure - Basic and Diluted Net Income (Loss) per Common Share (Tables) Sheet http://www.petrospharma.com/role/DisclosureBasicAndDilutedNetIncomeLossPerCommonShareTables Basic and Diluted Net Income (Loss) per Common Share (Tables) Tables http://www.petrospharma.com/role/DisclosureBasicAndDilutedNetIncomeLossPerCommonShare 33 false false R34.htm 31503 - Disclosure - Segment Information (Tables) Sheet http://www.petrospharma.com/role/DisclosureSegmentInformationTables Segment Information (Tables) Tables http://www.petrospharma.com/role/DisclosureSegmentInformation 34 false false R35.htm 40101 - Disclosure - Nature of Operations, Basis of Presentation, Liquidity and Going Concern - Additional information (Details) Sheet http://www.petrospharma.com/role/DisclosureNatureOfOperationsBasisOfPresentationLiquidityAndGoingConcernAdditionalInformationDetails Nature of Operations, Basis of Presentation, Liquidity and Going Concern - Additional information (Details) Details 35 false false R36.htm 40201 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.petrospharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.petrospharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies 36 false false R37.htm 40301 - Disclosure - Accounts Receivable, net (Details) Sheet http://www.petrospharma.com/role/DisclosureAccountsReceivableNetDetails Accounts Receivable, net (Details) Details http://www.petrospharma.com/role/DisclosureAccountsReceivableNetTables 37 false false R38.htm 40302 - Disclosure - Accounts Receivable, net - Additional information (Details) Sheet http://www.petrospharma.com/role/DisclosureAccountsReceivableNetAdditionalInformationDetails Accounts Receivable, net - Additional information (Details) Details 38 false false R39.htm 40401 - Disclosure - Inventories (Details) Sheet http://www.petrospharma.com/role/DisclosureInventoriesDetails Inventories (Details) Details http://www.petrospharma.com/role/DisclosureInventoriesTables 39 false false R40.htm 40402 - Disclosure - Inventories - Additional Information (Details) Sheet http://www.petrospharma.com/role/DisclosureInventoriesAdditionalInformationDetails Inventories - Additional Information (Details) Details 40 false false R41.htm 40501 - Disclosure - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.petrospharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsDetails Prepaid Expenses and Other Current Assets (Details) Details http://www.petrospharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables 41 false false R42.htm 40601 - Disclosure - Intangible Assets (Details) Sheet http://www.petrospharma.com/role/DisclosureIntangibleAssetsDetails Intangible Assets (Details) Details http://www.petrospharma.com/role/DisclosureIntangibleAssetsTables 42 false false R43.htm 40602 - Disclosure - Intangible Assets - Future annual amortization (Details) Sheet http://www.petrospharma.com/role/DisclosureIntangibleAssetsFutureAnnualAmortizationDetails Intangible Assets - Future annual amortization (Details) Details 43 false false R44.htm 40603 - Disclosure - Intangible Assets - Additional Information (Details) Sheet http://www.petrospharma.com/role/DisclosureIntangibleAssetsAdditionalInformationDetails Intangible Assets - Additional Information (Details) Details 44 false false R45.htm 40701 - Disclosure - Accrued Expenses (Details) Sheet http://www.petrospharma.com/role/DisclosureAccruedExpensesDetails Accrued Expenses (Details) Details http://www.petrospharma.com/role/DisclosureAccruedExpensesTables 45 false false R46.htm 40801 - Disclosure - Debt - Promissory Note (Details) Sheet http://www.petrospharma.com/role/DisclosureDebtPromissoryNoteDetails Debt - Promissory Note (Details) Details 46 false false R47.htm 40802 - Disclosure - Debt - Future minimum principal payments (Details) Sheet http://www.petrospharma.com/role/DisclosureDebtFutureMinimumPrincipalPaymentsDetails Debt - Future minimum principal payments (Details) Details 47 false false R48.htm 40901 - Disclosure - Operating Leases - (Details) Sheet http://www.petrospharma.com/role/DisclosureOperatingLeasesDetails Operating Leases - (Details) Details http://www.petrospharma.com/role/DisclosureOperatingLeasesTables 48 false false R49.htm 40902 - Disclosure - Operating Leases - Lease expense (Details) Sheet http://www.petrospharma.com/role/DisclosureOperatingLeasesLeaseExpenseDetails Operating Leases - Lease expense (Details) Details 49 false false R50.htm 40903 - Disclosure - Operating Leases - Supplemental balance sheet information related to leases (Details) Sheet http://www.petrospharma.com/role/DisclosureOperatingLeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails Operating Leases - Supplemental balance sheet information related to leases (Details) Details 50 false false R51.htm 40904 - Disclosure - Operating Leases - Supplemental lease term and discount rate information (Details) Sheet http://www.petrospharma.com/role/DisclosureOperatingLeasesSupplementalLeaseTermAndDiscountRateInformationDetails Operating Leases - Supplemental lease term and discount rate information (Details) Details 51 false false R52.htm 40905 - Disclosure - Operating Leases - Future minimum lease payments under non-cancelable leases (Details) Sheet http://www.petrospharma.com/role/DisclosureOperatingLeasesFutureMinimumLeasePaymentsUnderNonCancelableLeasesDetails Operating Leases - Future minimum lease payments under non-cancelable leases (Details) Details 52 false false R53.htm 40906 - Disclosure - Operating Leases - Future minimum sublease income under non-cancelable leases (Details) Sheet http://www.petrospharma.com/role/DisclosureOperatingLeasesFutureMinimumSubleaseIncomeUnderNonCancelableLeasesDetails Operating Leases - Future minimum sublease income under non-cancelable leases (Details) Details 53 false false R54.htm 40907 - Disclosure - Operating Leases - Additional information (Details) Sheet http://www.petrospharma.com/role/DisclosureOperatingLeasesAdditionalInformationDetails Operating Leases - Additional information (Details) Details 54 false false R55.htm 41001 - Disclosure - Stock Options and Restricted Stock Units ("RSU's") (Details) Sheet http://www.petrospharma.com/role/DisclosureStockOptionsAndRestrictedStockUnitsrsuSDetails Stock Options and Restricted Stock Units ("RSU's") (Details) Details http://www.petrospharma.com/role/DisclosureStockOptionsAndRestrictedStockUnitsrsuSTables 55 false false R56.htm 41002 - Disclosure - Stock Options and Restricted Stock Units ("RSU's") - Summary of stock options (Details) Sheet http://www.petrospharma.com/role/DisclosureStockOptionsAndRestrictedStockUnitsrsuSSummaryOfStockOptionsDetails Stock Options and Restricted Stock Units ("RSU's") - Summary of stock options (Details) Details http://www.petrospharma.com/role/DisclosureStockOptionsAndRestrictedStockUnitsrsuSTables 56 false false R57.htm 41003 - Disclosure - Stock Options and Restricted Stock Units ("RSU's") - Additional Information (Details) Sheet http://www.petrospharma.com/role/DisclosureStockOptionsAndRestrictedStockUnitsrsuSAdditionalInformationDetails Stock Options and Restricted Stock Units ("RSU's") - Additional Information (Details) Details http://www.petrospharma.com/role/DisclosureStockOptionsAndRestrictedStockUnitsrsuSTables 57 false false R58.htm 41101 - Disclosure - Common Stock Warrants - Company's warrants by expiration date (Details) Sheet http://www.petrospharma.com/role/DisclosureCommonStockWarrantsCompanySWarrantsByExpirationDateDetails Common Stock Warrants - Company's warrants by expiration date (Details) Details 58 false false R59.htm 41201 - Disclosure - Basic and Diluted Net Income (Loss) per Common Share - Reconciliation of the weighted average number of common shares outstanding used in calculating basic and diluted net loss per share (Details) Sheet http://www.petrospharma.com/role/DisclosureBasicAndDilutedNetIncomeLossPerCommonShareReconciliationOfWeightedAverageNumberOfCommonSharesOutstandingUsedInCalculatingBasicAndDilutedNetLossPerShareDetails Basic and Diluted Net Income (Loss) per Common Share - Reconciliation of the weighted average number of common shares outstanding used in calculating basic and diluted net loss per share (Details) Details http://www.petrospharma.com/role/DisclosureBasicAndDilutedNetIncomeLossPerCommonShareTables 59 false false R60.htm 41202 - Disclosure - Basic and Diluted Net Income (Loss) per Common Share - Potentially dilutive securities convertible into common shares that were excluded from the calculation of diluted net income (loss) per share (Details) Sheet http://www.petrospharma.com/role/DisclosureBasicAndDilutedNetIncomeLossPerCommonSharePotentiallyDilutiveSecuritiesConvertibleIntoCommonSharesThatWereExcludedFromCalculationOfDilutedNetIncomeLossPerShareDetails Basic and Diluted Net Income (Loss) per Common Share - Potentially dilutive securities convertible into common shares that were excluded from the calculation of diluted net income (loss) per share (Details) Details http://www.petrospharma.com/role/DisclosureBasicAndDilutedNetIncomeLossPerCommonShareTables 60 false false R61.htm 41301 - Disclosure - Marketing, Licensing and Distribution Agreements - Vivus (Details) Sheet http://www.petrospharma.com/role/DisclosureMarketingLicensingAndDistributionAgreementsVivusDetails Marketing, Licensing and Distribution Agreements - Vivus (Details) Details http://www.petrospharma.com/role/DisclosureMarketingLicensingAndDistributionAgreements 61 false false R62.htm 41501 - Disclosure - Segment Information (Details) Sheet http://www.petrospharma.com/role/DisclosureSegmentInformationDetails Segment Information (Details) Details http://www.petrospharma.com/role/DisclosureSegmentInformationTables 62 false false R63.htm 41502 - Disclosure - Segment Information - Net Sales by Geographic region (Details) Sheet http://www.petrospharma.com/role/DisclosureSegmentInformationNetSalesByGeographicRegionDetails Segment Information - Net Sales by Geographic region (Details) Details 63 false false R64.htm 41503 - Disclosure - Segment Information - Segment assets (Details) Sheet http://www.petrospharma.com/role/DisclosureSegmentInformationSegmentAssetsDetails Segment Information - Segment assets (Details) Details 64 false false R65.htm 41601 - Disclosure - Subsequent Events (Details) Sheet http://www.petrospharma.com/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) Details http://www.petrospharma.com/role/DisclosureSubsequentEvents 65 false false All Reports Book All Reports tmb-20230630x10q.htm tmb-20230630.xsd tmb-20230630_cal.xml tmb-20230630_def.xml tmb-20230630_lab.xml tmb-20230630_pre.xml tmb-20230630xex31d1.htm tmb-20230630xex31d2.htm tmb-20230630xex32.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true